Frontlight ResearchEarly access
Trial site
City of Hope Cancer Center
- 9running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Colorectal cancer3 trials
- Liver and biliary tract cancer3 trials
- Ovarian cancer3 trials
- Prostate cancer3 trials
- Cervical cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Gastric and oesophageal cancer2 trials
- Glioblastoma2 trials
- Kidney cancer2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- and 11 more
- Phase
- Phase 14 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 33 trials
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Completed3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Celgene1 trial
- Dana-Farber Cancer Institute1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Janssen Research & Development, LLC1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026